Valeant Completes Aton Pharma Purchase

Drug developer Valeant Pharmaceuticals International said Thursday it has completed a $318 million acquisition of the specialty drug company Aton Pharma Inc.

ALISO VIEJO, Calif. (AP) -- Drug developer Valeant Pharmaceuticals International said Thursday it has completed an acquisition of the specialty drug company Aton Pharma Inc.

Valeant, which is based in Aliso Viejo, Calif., said earlier this month it planned to buy Aton for about $318 million.

Aton is based in Lawrenceville, N.J.

More in Supply Chain